Covalon Technologies (TSXV:COV) announced today that it appointed Brent Ashton as its new CEO and as a board director.
Ashton’s appointment goes into effect immediately. The medtech industry veteran has experience leading large business units for wound care, vascular access, infection prevention and diagnostics. His track record includes time spent at large medtech companies like 3M and BD.
Covalon develops technologies and solutions for advanced wound care, infection prevention, and medical device coatings. The company believes that, with his broad experience, Ashton can lead the company into its next phase of growth and development.
Board Chair Amir Boloor has served as interim CEO since September when former CEO Brian Pedlar departed the corner office.
“On behalf of the board, I am delighted to welcome Mr. Brent Ashton to Covalon as its new CEO,” Boloor said. “Brent’s extensive medtech industry expertise specifically as it rel…